Fetal MRI can ID brain malformation earlier than traditional imaging

New research has found fetal MRI can reliably identify holoprosencephaly as early as 18 weeks into pregnancy, providing added time for parents to understand and prepare for the condition. 

"Because of the strong link between the severity of brain abnormality and clinical outcomes, such early and accurate imaging is important for counseling families,” said lead author Youssef A. Kousa, PhD, a child neurology fellow at Children’s National Health System. “Our findings and our detailed descriptions of the differences between disease variants should help to inform these important conversations during complicated pregnancies."

In the study, published in the American Journal of Medical Genetics, researchers used advanced MRI protocol to show radiographic data consistent with diagnosing along the holoprosencephaly spectrum. 

Ultrasound and fetal sonography have been shown to detect the brain malformation based on abnormal facial features, but these modalities not effective until 24 weeks—leaving little time for families to develop a care plan, authors wrote.  

“Accurate prenatal evaluation is important because the severity of imaging findings correlates with postnatal morbidity and mortality in holoprosencephaly. ... [T]his work has implications for the evaluation, diagnosis, management and genetic counseling that families can receive during a pregnancy,” Kousa et al. wrote.

""

Matt joined Chicago’s TriMed team in 2018 covering all areas of health imaging after two years reporting on the hospital field. He holds a bachelor’s in English from UIC, and enjoys a good cup of coffee and an interesting documentary.

Around the web

Smaller health systems are increasingly moving into this realm. Tim Kearns, director of marketing and healthcare IT, Konica Minolta Imaging USA, explains the implications.

 

The healthcare market analysis firm Signify Research released a list of predictions in radiology its analysts expect to see in 2025. 

Jessica Porembka, MD, of the breast imaging division at University of Texas Southwestern Medical Center, said an ultrasound-first strategy for these lesions in DBT is cost-effective and improves efficiency.